BERKELEY, Calif., Nov. 3, 2023 /PRNewswire/ — Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today that it will present preclinical data of its lead asset, ACTM-838, in a poster presentation at the 2023 38th Society for Immunotherapy of Cancer (SITC)…
News Ticker
- [ November 30, 2023 ] Cell Culture Manufacturing Specialist – TekwissenGroup – Berkeley, CA San Francisco Biotech Jobs
- [ November 30, 2023 ] By the Bay Health, Mission Hospice & Home Care, and Hope Hospice Merge to Become the Largest Independent Not-for-Profit Hospice Network in Northern California News
- [ November 30, 2023 ] Plant-based menstrual pads could help alleviate period poverty News
- [ November 30, 2023 ] Atropos Health Forms Life Science Advisory Board, Increasing Commitment to Accelerated Drug Development and Clinical Trial Diversity and Inclusion News
- [ November 30, 2023 ] PsiQuantum Announces New Government Advisory Board with Decades of Combined Public Service Across the White House, Departments of Defense and Commerce, Intelligence Community, and the U.S. Congress News
Copyright © 2023 Biotech Networks, LLC
